Tempol ameliorates STZ-induced T1DM potentially via enhancing AMPK signaling, suppressing pro-apoptotic activity, promoting progenitor cells recruitment, and restoring glucose transporters level

This publication has 71 references indexed in Scilit:

• Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects
  BioDrugs, 2025
• Advancements in utilizing CD34+ stem cells for repairing diabetic vascular damage
  Biochemical and Biophysical Research Communications, 2025
• The role of GLUT2 in glucose metabolism in multiple organs and tissues
  Molecular Biology Reports, 2023
• Tempol reduces inflammation and oxidative damage in cigarette smoke-exposed mice by decreasing neutrophil infiltration and activating the Nrf2 pathway
  Chemico-Biological Interactions, 2020
• Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease
  Pflügers Archiv - European Journal of Physiology, 2020
• VEGF-A and blood vessels: a beta cell perspective
  Diabetologia, 2019
• The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes)
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
• Histone deacetylase inhibitor MGCD0103 protects the pancreas from streptozotocin-induced oxidative stress and β-cell death
  Biomedicine & Pharmacotherapy, 2019
• The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy
  European Journal of Pharmacology, 2017
• 5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications
  Acta Pharmaceutica Sinica B, 2016